Vernacare, a portfolio company of H.I.G. Capital carved out the infection prevention business from Frontier Medical Group, including the brands Sharpsafe, Clinisafe and eXchange. Terms of the transaction were not disclosed.
The acquired businesses are engaged in the infection prevention market and provide a range of sharps and clinical waste disposal solutions. Sharpsafe was the world’s first purpose-designed plastic sharps container. With a customer base across the UK and Europe, the business operates from its site in Blackwood, Wales.
“The Frontier infection prevention business is a growing industry leader in the manufacture and supply of products that contain and dispose of infectious material safely — critical systems in protecting the healthcare workforce and limiting the spread of infection,” James Mitchell, principal at H.I.G. Capital in London, said. “H.I.G. is looking forward to working with Frontier Medical’s infection prevention business, which is highly complementary to Vernacare’s existing presence in the clinical infection prevention sector. We believe the combination will strengthen Vernacare’s market position and support an ambitious organic growth strategy. We will also continue to pursue similar accretive acquisitions in the sector across the UK and internationally over the coming years.”
“Frontier’s infection prevention business and Vernacare fit very well together, with a common focus on best practice within infection prevention, and together, will be even better placed to help improve infection prevention standards within UK and overseas healthcare systems,” James Steele, CEO of Vernacare, said.
H.I.G. Capital is a global alternative asset manager with more than €34 billion ($38.9 billion) of equity capital under management.
